FULGENT GENETICS, INC. Lease, Cost
FULGENT GENETICS, INC. (FLGT) reported Lease, Cost of $1.28 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2026-07-30
- FULGENT GENETICS, INC. lease, cost for the quarter ending 2026-06-30 was $1.28M, a 36.91% increase year-over-year.
- FULGENT GENETICS, INC. lease, cost for the quarter ending 2026-03-31 was $1.28M, a 12.79% increase year-over-year.
- FULGENT GENETICS, INC. lease, cost for the quarter ending 2025-12-31 was $1.13M, a 22.63% increase year-over-year.
- FULGENT GENETICS, INC. lease, cost for the quarter ending 2025-09-30 was $1.07M, a 15.83% decline year-over-year.
- FULGENT GENETICS, INC. lease, cost for fiscal 2025 was $4.26M, a 30.13% decline from fiscal 2024.
- FULGENT GENETICS, INC. lease, cost for fiscal 2024 was $6.10M, a 35.59% decline from fiscal 2023.
- FULGENT GENETICS, INC. lease, cost for fiscal 2023 was $9.47M, a 22.44% increase from fiscal 2022.
- FULGENT GENETICS, INC. lease, cost for fiscal 2022 was $7.74M, a 393.93% increase from fiscal 2021.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.28M 10-Q · filed 2026-07-30 | $2.33M 10-Q · filed 2026-07-30 | $3.68M derived: sum of 3 quarters · filed 2026-07-30 | $4.75M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $1.28M 10-Q · filed 2026-05-01 | $2.41M derived: sum of 2 quarters · filed 2026-05-01 | $3.48M derived: sum of 3 quarters · filed 2026-05-01 | $4.41M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $1.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $2.20M derived: sum of 2 quarters · filed 2026-02-27 | $3.13M derived: sum of 3 quarters · filed 2026-07-30 | $4.26M 10-K · filed 2026-02-27 |
| 2025-09-30 | $1.07M 10-Q · filed 2025-11-07 | $2.00M derived: sum of 2 quarters · filed 2026-07-30 | $3.13M 10-Q · filed 2025-11-07 | $4.05M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $932.00K 10-Q · filed 2026-07-30 | $2.07M 10-Q · filed 2026-07-30 | $2.98M derived: sum of 3 quarters · filed 2026-07-30 | $4.25M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $1.13M 10-Q · filed 2026-05-01 | $2.05M derived: sum of 2 quarters · filed 2026-05-01 | $3.32M derived: sum of 3 quarters · filed 2026-05-01 | $5.14M derived: sum of 4 quarters · filed 2026-05-01 |
| 2024-12-31 | $919.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $2.19M derived: sum of 2 quarters · filed 2026-02-27 | $4.01M derived: sum of 3 quarters · filed 2026-02-27 | $6.10M 10-K · filed 2026-02-27 |
| 2024-09-30 | $1.27M 10-Q · filed 2025-11-07 | $3.09M derived: sum of 2 quarters · filed 2025-11-07 | $5.18M 10-Q · filed 2025-11-07 | $7.26M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $1.82M 10-Q · filed 2025-08-01 | $3.91M 10-Q · filed 2025-08-01 | $5.99M derived: sum of 3 quarters · filed 2026-02-27 | $8.30M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $2.09M 10-Q · filed 2025-05-02 | $4.18M derived: sum of 2 quarters · filed 2026-02-27 | $6.48M derived: sum of 3 quarters · filed 2026-02-27 | $9.09M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $2.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $4.39M derived: sum of 2 quarters · filed 2026-02-27 | $7.00M derived: sum of 3 quarters · filed 2026-02-27 | $9.47M 10-K · filed 2026-02-27 |
| 2023-09-30 | $2.31M 10-Q · filed 2024-11-08 | $4.92M derived: sum of 2 quarters · filed 2024-11-08 | $7.39M 10-Q · filed 2024-11-08 | $9.85M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $2.61M 10-Q · filed 2024-08-02 | $5.08M 10-Q · filed 2024-08-02 | $7.54M derived: sum of 3 quarters · filed 2025-02-28 | $9.68M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $2.47M 10-Q · filed 2024-05-03 | $4.94M derived: sum of 2 quarters · filed 2025-02-28 | $7.07M derived: sum of 3 quarters · filed 2025-02-28 | $9.46M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $2.46M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $4.60M derived: sum of 2 quarters · filed 2025-02-28 | $6.99M derived: sum of 3 quarters · filed 2025-02-28 | $7.74M 10-K · filed 2025-02-28 |
| 2022-09-30 | $2.14M 10-Q · filed 2023-11-03 | $4.53M derived: sum of 2 quarters · filed 2023-11-03 | $5.27M 10-Q · filed 2023-11-03 | $5.86M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $2.39M 10-Q · filed 2023-08-04 | $3.13M 10-Q · filed 2023-08-04 | $3.72M derived: sum of 3 quarters · filed 2024-02-28 | $4.21M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $745.00K 10-Q · filed 2023-05-05 | $1.33M derived: sum of 2 quarters · filed 2024-02-28 | $1.82M derived: sum of 3 quarters · filed 2024-02-28 | $2.11M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $588.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $1.07M derived: sum of 2 quarters · filed 2024-02-28 | $1.37M derived: sum of 3 quarters · filed 2024-02-28 | $1.57M 10-K · filed 2024-02-28 |
| 2021-09-30 | $485.00K 10-Q · filed 2022-11-07 | $778.00K derived: sum of 2 quarters · filed 2022-11-07 | $978.00K 10-Q · filed 2022-11-07 | $1.16M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $293.00K 10-Q · filed 2022-08-04 | $493.00K 10-Q · filed 2022-08-04 | $674.00K derived: sum of 3 quarters · filed 2023-02-28 | $897.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $200.00K 10-Q · filed 2022-05-05 | $381.00K derived: sum of 2 quarters · filed 2023-02-28 | $604.00K derived: sum of 3 quarters · filed 2023-02-28 | $759.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $181.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $404.00K derived: sum of 2 quarters · filed 2023-02-28 | $559.00K derived: sum of 3 quarters · filed 2023-02-28 | $708.00K 10-K · filed 2023-02-28 |
| 2020-09-30 | $223.00K 10-Q · filed 2021-11-09 | $378.00K derived: sum of 2 quarters · filed 2021-11-09 | $527.00K 10-Q · filed 2021-11-09 | $676.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $155.00K 10-Q · filed 2021-08-10 | $304.00K 10-Q · filed 2021-08-10 | $453.00K derived: sum of 3 quarters · filed 2022-02-28 | $599.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $149.00K 10-Q · filed 2021-05-07 | $298.00K derived: sum of 2 quarters · filed 2022-02-28 | $444.00K derived: sum of 3 quarters · filed 2022-02-28 | $590.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $149.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $295.00K derived: sum of 2 quarters · filed 2022-02-28 | $441.00K derived: sum of 3 quarters · filed 2022-02-28 | $587.00K 10-K · filed 2022-02-28 |
| 2019-09-30 | $146.00K 10-Q · filed 2020-11-09 | $292.00K derived: sum of 2 quarters · filed 2020-11-09 | $438.00K 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $146.00K 10-Q · filed 2020-08-05 | $292.00K 10-Q · filed 2020-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |